Market Overview

Galderma Laboratories Announces the National Launch of qilib™, a Breakthrough, New Hair Care Line Created to Regrow, Revitalize and Improve Hair Health

Share:
FT. WORTH, Texas--(BUSINESS WIRE)--

Galderma Laboratories, L.P., a global leader focused on medical solutions in dermatology and skin health and the maker of Cetaphil®, today announced the launch and nationwide availability of qilib™ Hair Regrowth + Revitalization System and qilib™ Hair Health Reinforcement Biotin + Multivitamin Supplement. Leveraging the company's expertise and history in skin health, the qilib portfolio features a breakthrough, dual action system to address hair thinning and hair loss. Despite the 80 million men and women in the US who suffer from hair loss, there has been little innovation since minoxidil was approved for over the counter use nearly 20 years ago.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160304005508/en/

qilib™ Hair Regrowth + Revitalization System (Photo: Business Wire)

qilib™ Hair Regrowth + Revitalization System (Photo: Business Wire)

"The qilib Hair Regrowth + Revitalization System is a game changer because it showed clinical results in both men and women in as early as 4 weeks," says Amy McMichael, M.D., board-certified dermatologist and Professor and Chair of Dermatology at Wake Forest University School of Medicine. "For men and women frustrated with their current hair loss treatments, I encourage them to try qilib and see for themselves what a difference it can make to their hair."

The qilib system is made of up the Hair Regrowth Treatment, which contains clinically proven, prescription-strength minoxidil specifically formulated for men (5% minoxidil) or women (2% minoxidil), and the Hair Revitalizing Solution formulated with natural botanicals. The Hair Regrowth Treatment works by helping to awaken and restore dormant hair follicles so new hair can grow again, while the qilib™ Hair Revitalizing Solution nourishes the skin of the scalp with natural botanical ingredients, vitamin C, proteins, lipids and antioxidants. When used as directed, 70% of male and more than 75% of female participants were "satisfied with overall improvement" at 12 weeks of use. Both the Hair Regrowth Treatment and the Hair Revitalizing Solution come in an easy-to-use spray bottle.

"Delivering innovative solutions to improve people's health and self-confidence is a core value at Galderma," says Miles Harrison, President and General Manager of Galderma Laboratories, L.P. "qilib's launch embodies our pioneering approach to address skin care issues, including those associated with the hair and scalp, with solutions backed by science. The millions of sufferers of thinning hair and hair loss have had limited options that work, but now, qilib Hair Regrowth + Revitalization System is available to provide fast, visible results in as little as 4 weeks."

qilib™ Hair Health Reinforcement Biotin + Multivitamin Supplement is made up of 5,000 mcg biotin, a key ingredient to help support healthy hair and scalp, and multiple vitamins, including the daily recommended dose of Vitamins B12, C, D3, E.1 Developed in partnership with, and tested by dermatologists, both qilib™ Hair Regrowth + Revitalization System and qilib™ Hair Health Reinforcement Biotin + Multivitamin Supplement are suitable for any hair type.

About qilib

qilib™ Hair Regrowth + Revitalization System (manufacturer suggested retail price (MSRP) of $45.99 for a one month supply) and qilib Hair Health Reinforcement Biotin + Multivitamin Supplement (MSRP $9.99 for 30 tablets and $16.99 for 90 tablets) is currently available in CVS, Walgreen's, Target, Amazon.com, Drugstore.com, and will soon be offered at Walmart. The components of the qilib™ Hair Regrowth + Revitalization System, the Hair Regrowth Treatment (MSRP $22.49) and Hair Revitalization Solution (MSRP $33.99) are also available for purchase separately.

For more information, visit qilib.us.

About Hair Loss

In the U.S., over 80 million men and women experience hair loss. Almost half of all women experience pattern hair loss, also known as androgenic alopecia, at some point in their lives. About two-thirds of men experience pattern hair loss by the time they reach 35. Primary causes of hair loss include certain medications, genetics, the change in hormones during and after pregnancy (for women), thyroid disorders and anemia. Autoimmune disorders (e.g. psoriasis, seborrheic dermatitis), extreme stress, physical trauma, and dramatic weight loss can also trigger hair loss.

About Galderma

Dating back to 1961, Galderma is now present in 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails.

Strategic brands in the U.S. include Epiduo® Gel, Epiduo® Forte Gel, Oracea® Capsules, Clobex® Spray, Differin® Gel, Mirvaso® Gel, MetroGel® Gel, Soolantra® Cream, Vectical® Cream, Tri-Luma® Cream, Cetaphil®, Benzac® Acne Solutions, Restylane®, Restylane® Silk, Restylane® Lyft, Dysport® (abobotulinumtoxinA) and Sculptra® Aesthetic.

For more information, please visit www.galderma.com and www.galdermausa.com.

1 These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Galderma
Virginie Naigeon
Director of Corporate Communications, U.S.
virginie.naigeon@galderma.com
or
Twist Mktg
Amanda Loder, 212-259-0491
aloder@w2ogroup.com

View Comments and Join the Discussion!